cuprizone has been researched along with valproic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casaccia-Bonnefil, P; Dupree, J; Franklin, RJ; Li, J; Sandoval, J; Shen, S; Swiss, VA | 1 |
| Gan, G; He, Y; Hu, Y; Liu, X; Yang, J; Yao, Y; Zhang, A; Zhang, C; Zhu, X | 1 |
2 other study(ies) available for cuprizone and valproic acid
| Article | Year |
|---|---|
Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency.
Topics: Aging; Animals; Animals, Newborn; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Differentiation; Cells, Cultured; Cerebral Cortex; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Enzyme Inhibitors; Epigenesis, Genetic; Glial Fibrillary Acidic Protein; Histone Deacetylases; Mice; Mice, Inbred C57BL; Microglia; Microscopy, Electron, Transmission; Myelin Proteins; Neurosecretory Systems; Rats; Regeneration; Stem Cells; Time Factors; Transcription Factors; Transcription, Genetic; Valproic Acid | 2008 |
Valproic acid suppresses cuprizone-induced hippocampal demyelination and anxiety-like behavior by promoting cholesterol biosynthesis.
Topics: Animals; Anxiety; Cholesterol; Cuprizone; Demyelinating Diseases; Hippocampus; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Multiple Sclerosis; Neuroprotective Agents; Psychomotor Performance; Valproic Acid | 2021 |